Search

everythinglearnresearchcommunity

for

Search:↓

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

Certain Dibenzo derivatives may help treat prostate cancer.

Neurosteroids help control dopamine responses in the brain.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Compound 7b is a promising candidate for treating benign prostatic hyperplasia and prostate cancer.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

LY191704 is a compound that effectively blocks a specific enzyme involved in hormone conversion and could help treat enlarged prostate and hair loss.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

The developed model can predict effective 5-alpha-reductase enzyme inhibitors.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

4-(4-Phenoxybenzoyl)benzoic acid derivatives can both increase and decrease certain types of reactive oxygen species, and may be relevant to hair loss.

Cortisone suppresses hair regrowth, especially undercoat hair, while adrenalectomy affects hair growth differently in rabbits and rats.

Thyroid receptor β can help develop new drugs to treat hair loss.

Mineralocorticoid receptor antagonist therapy does not significantly reduce mortality in COVID-19 patients.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Treatment for benign prostatic hyperplasia involves drugs that either quickly relieve symptoms or reduce prostate size, with a combination offering more benefits but more side effects.

New steroid compounds may help with hormonal therapy and have potential benefits for glucose disorders, but more research is needed.

Changing the C-ring structure in certain compounds can make them better at blocking a specific human enzyme.

Using a certain drug on the skin can help prevent hair loss caused by pulling on the hair.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

New compounds were made that effectively block enzymes related to prostate issues and hair loss.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

Three natural compounds from Ghanaian plants may help treat BPH and alopecia.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.